ZBTB25
gene geneOn this page
Also known as KUP
Summary
ZBTB25 (zinc finger and BTB domain containing 25, HGNC:13112) is a protein-coding gene on chromosome 14q23.3, encoding Zinc finger and BTB domain-containing protein 25 (P24278). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription repressor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in negative regulation of transcription by RNA polymerase II; regulation of cytokine production; and regulation of immune system process. Located in nucleoplasm.
Source: NCBI Gene 7597 — RefSeq curated summary.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 91 total — 1 pathogenic
- MANE Select transcript:
NM_006977
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13112 |
| Approved symbol | ZBTB25 |
| Name | zinc finger and BTB domain containing 25 |
| Location | 14q23.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KUP |
| Ensembl gene | ENSG00000089775 |
| Ensembl biotype | protein_coding |
| OMIM | 194541 |
| Entrez | 7597 |
Gene structure
Transcript identifiers
Ensembl transcripts: 33 — 33 protein_coding
ENST00000394715, ENST00000555220, ENST00000555424, ENST00000608382, ENST00000865241, ENST00000865242, ENST00000865243, ENST00000865244, ENST00000865245, ENST00000865246, ENST00000865247, ENST00000865248, ENST00000865249, ENST00000922501, ENST00000922502, ENST00000922503, ENST00000922504, ENST00000922505, ENST00000922506, ENST00000922507, ENST00000922508, ENST00000922509, ENST00000922510, ENST00000922511, ENST00000957083, ENST00000957084, ENST00000957085, ENST00000957086, ENST00000957087, ENST00000957088, ENST00000957089, ENST00000957090, ENST00000957091
RefSeq mRNA: 9 — MANE Select: NM_006977
NM_001304507, NM_001304508, NM_001354682, NM_001354683, NM_001354684, NM_001354685, NM_001354686, NM_001354687, NM_006977
CCDS: CCDS76689, CCDS9765
Canonical transcript exons
ENST00000608382 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000658429 | 64490361 | 64490540 |
| ENSE00001319158 | 64503661 | 64503838 |
| ENSE00003709408 | 64478051 | 64488057 |
Expression profiles
Bgee: expression breadth ubiquitous, 185 present calls, max score 84.76.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 27.2960 / max 420.6908, expressed in 1810 samples.
FANTOM5 promoters (13 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 143630 | 9.7802 | 1735 |
| 143632 | 4.8995 | 1354 |
| 143625 | 3.9500 | 1492 |
| 143631 | 3.0965 | 847 |
| 143626 | 1.3839 | 727 |
| 143628 | 1.0151 | 608 |
| 143629 | 0.8947 | 545 |
| 143627 | 0.8206 | 508 |
| 143635 | 0.5153 | 249 |
| 143634 | 0.3143 | 136 |
Top tissues by expression
286 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| apex of heart | UBERON:0002098 | 84.76 | gold quality |
| gastrocnemius | UBERON:0001388 | 82.97 | gold quality |
| muscle of leg | UBERON:0001383 | 82.69 | gold quality |
| mucosa of stomach | UBERON:0001199 | 81.61 | gold quality |
| calcaneal tendon | UBERON:0003701 | 81.16 | gold quality |
| right atrium auricular region | UBERON:0006631 | 80.98 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 80.87 | gold quality |
| right uterine tube | UBERON:0001302 | 80.80 | gold quality |
| heart left ventricle | UBERON:0002084 | 80.36 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 80.21 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 79.90 | gold quality |
| stromal cell of endometrium | CL:0002255 | 79.89 | gold quality |
| popliteal artery | UBERON:0002250 | 79.81 | gold quality |
| tibial artery | UBERON:0007610 | 79.81 | gold quality |
| granulocyte | CL:0000094 | 79.80 | gold quality |
| cardiac ventricle | UBERON:0002082 | 79.50 | gold quality |
| cardiac atrium | UBERON:0002081 | 79.32 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 78.98 | gold quality |
| tibial nerve | UBERON:0001323 | 78.95 | gold quality |
| aorta | UBERON:0000947 | 78.85 | gold quality |
| left ovary | UBERON:0002119 | 78.63 | gold quality |
| right ovary | UBERON:0002118 | 78.59 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 78.58 | gold quality |
| colonic epithelium | UBERON:0000397 | 78.54 | gold quality |
| left uterine tube | UBERON:0001303 | 78.52 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 78.50 | gold quality |
| lower esophagus | UBERON:0013473 | 78.46 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 78.44 | gold quality |
| heart | UBERON:0000948 | 78.35 | gold quality |
| left coronary artery | UBERON:0001626 | 78.34 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 7.23 |
| E-CURD-112 | no | 2.62 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 4)
- ZBTB25 functions as a negative regulator of nuclear factor of activated T cells (NF-AT) activation, such that RNA interference mediated knockdown resulted in enhanced activation of target genes. (PMID:20410506)
- study demonstrates that ZBTB25 regulates IAV (Influenza A virus) RNA transcription and replication and serves as a promising antiviral target for IAV treatment. (PMID:28768860)
- Transcription Repressor Protein ZBTB25 Associates with HDAC1-Sin3a Complex in Mycobacterium tuberculosis-Infected Macrophages, and Its Inhibition Clears Pathogen by Autophagy. (PMID:33627504)
- E3 ubiquitin ligase ZBTB25 suppresses beta coronavirus infection through ubiquitination of the main viral protease MPro. (PMID:37890782)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | zbtb25 | ENSDARG00000042383 |
| mus_musculus | Zbtb25 | ENSMUSG00000056459 |
| rattus_norvegicus | Zbtb25 | ENSRNOG00000006441 |
Paralogs (28): ZNF280C (ENSG00000056277), PRDM13 (ENSG00000112238), BCL6 (ENSG00000113916), FEZF1 (ENSG00000128610), ZBTB46 (ENSG00000130584), PRDM12 (ENSG00000130711), ZNF280D (ENSG00000137871), NACC2 (ENSG00000148411), FEZF2 (ENSG00000153266), ZBTB7B (ENSG00000160685), NACC1 (ENSG00000160877), BCL6B (ENSG00000161940), GFI1 (ENSG00000162676), GFI1B (ENSG00000165702), ZBTB49 (ENSG00000168826), ZNF280A (ENSG00000169548), ZNF581 (ENSG00000171425), ZNF524 (ENSG00000171443), ZBTB26 (ENSG00000171448), ZBTB21 (ENSG00000173276), ZNF683 (ENSG00000176083), ZBTB33 (ENSG00000177485), ZBTB3 (ENSG00000185670), ZBTB6 (ENSG00000186130), ZBTB14 (ENSG00000198081), ZBTB12 (ENSG00000204366), ZNF580 (ENSG00000213015), ZNF280B (ENSG00000275004)
Protein
Protein identifiers
Zinc finger and BTB domain-containing protein 25 — P24278 (reviewed: P24278)
Alternative names: Zinc finger protein 46, Zinc finger protein KUP
All UniProt accessions (3): P24278, G3V2K3, G3V351
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Tissue specificity. Expressed mainly in hematopoietic cells and testis.
RefSeq proteins (9): NP_001291436, NP_001291437, NP_001341611, NP_001341612, NP_001341613, NP_001341614, NP_001341615, NP_001341616, NP_008908* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000210 | BTB/POZ_dom | Domain |
| IPR011333 | SKP1/BTB/POZ_sf | Homologous_superfamily |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF00651
UniProt features (13 total): cross-link 7, sequence conflict 2, zinc finger region 2, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P24278-F1 | 59.17 | 0.21 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (7): 405, 142, 148, 198, 204, 303, 330
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 199 (showing top):
BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN, MYOGENIN_Q6, E2F4DP1_01, LFA1_Q6, GCANCTGNY_MYOD_Q6, MENSE_HYPOXIA_UP, RACCACAR_AML_Q6, CAGCTG_AP4_Q5, MORF_ZNF10, E2F_Q3, AML_Q6, GOBP_CYTOKINE_PRODUCTION, chr14q23, MODULE_98, AML1_01
GO Biological Process (3): negative regulation of transcription by RNA polymerase II (GO:0000122), regulation of cytokine production (GO:0001817), regulation of immune system process (GO:0002682)
GO Molecular Function (7): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227), DNA-binding transcription factor activity (GO:0003700), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (2): nucleoplasm (GO:0005654), nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of transcription by RNA polymerase II | 1 |
| transcription by RNA polymerase II | 1 |
| negative regulation of DNA-templated transcription | 1 |
| cytokine production | 1 |
| regulation of gene expression | 1 |
| regulation of multicellular organismal process | 1 |
| immune system process | 1 |
| regulation of biological process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| negative regulation of transcription by RNA polymerase II | 1 |
| DNA-binding transcription factor activity, RNA polymerase II-specific | 1 |
| DNA-binding transcription repressor activity | 1 |
| transcription cis-regulatory region binding | 1 |
| regulation of DNA-templated transcription | 1 |
| transcription regulator activity | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| nuclear lumen | 1 |
| cellular anatomical structure | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
882 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZBTB25 | WNK1 | P54963 | 581 |
| ZBTB25 | USHBP1 | Q8N6Y0 | 487 |
| ZBTB25 | CPA1 | P15085 | 448 |
| ZBTB25 | AK1 | P00568 | 447 |
| ZBTB25 | PIP4P1 | Q86T03 | 445 |
| ZBTB25 | PPP3R2 | Q96LZ3 | 433 |
| ZBTB25 | PPA1 | Q15181 | 419 |
| ZBTB25 | ZNF639 | Q9UID6 | 415 |
| ZBTB25 | GMCL1 | Q96IK5 | 407 |
| ZBTB25 | SLC9B1 | Q4ZJI4 | 398 |
| ZBTB25 | CHP1 | Q99653 | 398 |
| ZBTB25 | H3BQ15 | H3BQ15 | 394 |
| ZBTB25 | AMDHD2 | Q9Y303 | 393 |
| ZBTB25 | KPNA1 | P52294 | 382 |
| ZBTB25 | ZNF16 | P17020 | 374 |
IntAct
135 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZBTB25 | SEPHS1 | psi-mi:“MI:0915”(physical association) | 0.780 |
| ZBTB25 | TNIP1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| TNIP1 | ZBTB25 | psi-mi:“MI:0915”(physical association) | 0.720 |
| ZBTB25 | TRAF2 | psi-mi:“MI:0915”(physical association) | 0.670 |
| ZBTB25 | PNMA5 | psi-mi:“MI:0915”(physical association) | 0.670 |
| TRAF2 | ZBTB25 | psi-mi:“MI:0915”(physical association) | 0.670 |
| ZBTB25 | ZBTB1 | psi-mi:“MI:0915”(physical association) | 0.670 |
| ZBTB25 | ZBTB2 | psi-mi:“MI:0915”(physical association) | 0.670 |
| ZBTB2 | ZBTB25 | psi-mi:“MI:0914”(association) | 0.670 |
| CARNMT1 | NUP42 | psi-mi:“MI:0914”(association) | 0.640 |
| DDIT3 | ZBTB25 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZBTB25 | KCTD1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZBTB25 | APIP | psi-mi:“MI:0915”(physical association) | 0.560 |
| LZTS2 | ZBTB25 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TSSK3 | ZBTB25 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (67): ZBTB25 (Two-hybrid), ZBTB25 (Two-hybrid), ZBTB25 (Two-hybrid), TNIP1 (Two-hybrid), SEPHS1 (Two-hybrid), APIP (Two-hybrid), TSSK3 (Two-hybrid), LZTS2 (Two-hybrid), PNMA5 (Two-hybrid), KCTD1 (Two-hybrid), ZBTB25 (Reconstituted Complex), ZBTB25 (Affinity Capture-MS), ZBTB25 (Affinity Capture-MS), ZBTB25 (Two-hybrid), ZBTB25 (Two-hybrid)
ESM2 similar proteins: A0A5K7RLP0, A1YEX3, A7YWH3, B1WBU4, O15151, O35618, O43298, O88850, P24278, P97303, Q01954, Q0V8G8, Q15916, Q17RG1, Q562E2, Q5RC05, Q5RDQ6, Q5SXH7, Q5TC79, Q5VYS8, Q5W0Q7, Q5XIN1, Q6ZPY5, Q6ZSB9, Q6ZU67, Q7ZUW7, Q7ZYI3, Q8BLK9, Q8BSV3, Q8IW35, Q8K088, Q8N680, Q8N7W2, Q8TCN5, Q8VHI4, Q8WW38, Q90W33, Q96BR9, Q96S38, Q99ME3
Diamond homologs: A0JMG1, A1YEX3, B0WWP2, B3DIV9, B3M9V8, B3NDN0, B4GRJ2, B4HIK1, B4J045, B4L0G9, B4LIG6, B4MXW3, B4PD06, B4QLQ2, B7U179, D3Z8N4, D4A2K4, E0CZ16, E7F6F9, F1LZF0, F1MBP6, O14682, O22286, O35709, O43791, O81432, O95198, P0DMR5, P0DMR6, P24278, P28575, P34568, P58544, P58545, Q08DK3, Q08DS0, Q0D2A9, Q0IHH9, Q0VCW1, Q16RL8
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
91 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 71 |
| Likely benign | 12 |
| Benign | 4 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 2738637 | NM_005956.4(MTHFD1):c.2555del (p.Tyr852fs) | Pathogenic |
SpliceAI
1905 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 14:64449442:TAG:T | acceptor_loss | 1.0000 |
| 14:64449443:A:AG | acceptor_gain | 1.0000 |
| 14:64449443:A:G | acceptor_loss | 1.0000 |
| 14:64449443:AG:A | acceptor_gain | 1.0000 |
| 14:64449443:AGGAC:A | acceptor_gain | 1.0000 |
| 14:64449444:G:GA | acceptor_gain | 1.0000 |
| 14:64449444:G:GC | acceptor_loss | 1.0000 |
| 14:64449444:GG:G | acceptor_gain | 1.0000 |
| 14:64449444:GGAC:G | acceptor_gain | 1.0000 |
| 14:64449444:GGACG:G | acceptor_gain | 1.0000 |
| 14:64449619:CAAGG:C | donor_loss | 1.0000 |
| 14:64449620:AAG:A | donor_loss | 1.0000 |
| 14:64449623:G:C | donor_loss | 1.0000 |
| 14:64449624:T:A | donor_loss | 1.0000 |
| 14:64453752:A:AG | acceptor_gain | 1.0000 |
| 14:64453753:G:GG | acceptor_gain | 1.0000 |
| 14:64465609:CCTAC:C | donor_gain | 1.0000 |
| 14:64465610:CTAC:C | donor_gain | 1.0000 |
| 14:64465611:TAC:T | donor_gain | 1.0000 |
| 14:64465611:TACG:T | donor_loss | 1.0000 |
| 14:64465612:AC:A | donor_gain | 1.0000 |
| 14:64465614:G:GG | donor_gain | 1.0000 |
| 14:64465615:T:TC | donor_loss | 1.0000 |
| 14:64465618:G:GG | donor_gain | 1.0000 |
| 14:64490359:A:AC | donor_gain | 1.0000 |
| 14:64490359:AC:A | donor_gain | 1.0000 |
| 14:64490359:ACC:A | donor_loss | 1.0000 |
| 14:64490360:C:CC | donor_gain | 1.0000 |
| 14:64490360:CC:C | donor_gain | 1.0000 |
| 14:64490536:TGGTT:T | acceptor_gain | 1.0000 |
AlphaMissense
2892 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 14:64487926:A:G | L102P | 1.000 |
| 14:64487990:A:G | Y81H | 1.000 |
| 14:64488001:A:G | L77S | 1.000 |
| 14:64488013:A:G | F73S | 1.000 |
| 14:64490375:A:C | F53L | 1.000 |
| 14:64490375:A:T | F53L | 1.000 |
| 14:64490377:A:G | F53L | 1.000 |
| 14:64490387:G:C | F49L | 1.000 |
| 14:64490387:G:T | F49L | 1.000 |
| 14:64490388:A:G | F49S | 1.000 |
| 14:64490389:A:G | F49L | 1.000 |
| 14:64490397:G:A | S46F | 1.000 |
| 14:64490397:G:T | S46Y | 1.000 |
| 14:64490398:A:G | S46P | 1.000 |
| 14:64490399:A:C | F45L | 1.000 |
| 14:64490399:A:T | F45L | 1.000 |
| 14:64490401:A:G | F45L | 1.000 |
| 14:64490403:G:T | A44D | 1.000 |
| 14:64490406:G:T | A43D | 1.000 |
| 14:64490409:A:C | L42R | 1.000 |
| 14:64490409:A:G | L42P | 1.000 |
| 14:64490409:A:T | L42H | 1.000 |
| 14:64490420:G:C | H38Q | 1.000 |
| 14:64490420:G:T | H38Q | 1.000 |
| 14:64490422:G:C | H38D | 1.000 |
| 14:64490424:G:T | A37D | 1.000 |
| 14:64490429:G:C | F35L | 1.000 |
| 14:64490429:G:T | F35L | 1.000 |
| 14:64490430:A:G | F35S | 1.000 |
| 14:64490431:A:G | F35L | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000036268 (14:64472171 A>T), RS1000133290 (14:64493147 A>G,T), RS1000163932 (14:64478551 T>C,G), RS1000169706 (14:64477938 T>C), RS1000283333 (14:64486506 A>C,G), RS1000302372 (14:64505835 C>A,G), RS1000323786 (14:64504310 G>A,T), RS1000335895 (14:64486809 A>G), RS1000339816 (14:64458107 T>A), RS1000398635 (14:64480391 C>A,G), RS1000507083 (14:64474792 T>A), RS1000535342 (14:64491115 C>T), RS1000558731 (14:64475196 T>C), RS1000585302 (14:64493484 C>T), RS1000765354 (14:64467431 T>C)
Disease associations
OMIM: gene MIM:194541 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004627_154 | Lymphocyte count | 2.000000e-12 |
| GCST004632_40 | Lymphocyte percentage of white cells | 2.000000e-09 |
| GCST006979_1005 | Heel bone mineral density | 2.000000e-11 |
| GCST90002389_486 | Lymphocyte percentage of white cells | 2.000000e-26 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004587 | lymphocyte count |
| EFO:0007993 | lymphocyte percentage of leukocytes |
| EFO:0009270 | heel bone mineral density |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: enzyme — E3 ubiquitin ligase components
CTD chemical–gene interactions
26 total (human), top 26 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Arsenic | affects methylation, affects cotreatment, decreases expression, increases abundance, affects expression | 3 |
| bisphenol A | affects expression, affects cotreatment, decreases methylation | 2 |
| sodium arsenite | decreases expression, affects cotreatment, increases abundance | 2 |
| Valproic Acid | affects expression, increases methylation | 2 |
| TAK-243 | increases sumoylation | 1 |
| cobaltous chloride | decreases expression | 1 |
| manganese chloride | affects cotreatment, decreases expression, increases abundance | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| abrine | increases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Fulvestrant | affects cotreatment, decreases methylation | 1 |
| Leflunomide | increases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Air Pollutants, Occupational | affects expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Hydrogen Peroxide | affects cotreatment, decreases expression | 1 |
| Manganese | affects cotreatment, decreases expression, increases abundance | 1 |
| Phthalic Acids | increases methylation | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Theophylline | affects cotreatment, decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Cyclosporine | increases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
| Acrylamide | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.